Clinical trial · Observational
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell
NCT01591512CI-TRIAL-00017064terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Decision was made by Sponsor to stop the trial.
Summary
Brief summary (as posted)
The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Small Cell Lung Cancer | Lung Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 * Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results * Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy. * Able to understand and willing to provide Informed Consent Exclusion Criteria: * No diagnosis of SCLC * Not scheduled to undergo treatment for the diagnosis of SCLC * Unable to provide Informed Consent
References
Publications (0)
Data not yet available
No reference posted for this study.